- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Hospital
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
Setting: Intensive care unit
Hospital intensive care unit (ICU) ward
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Monoclonal antibodies
- Immunomodulator
- Antineoplastic agent
- Imatinib
- Infliximab
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Adults (18-64 years)
- General population
- Hospital
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Outpatient clinic
- Intensive care unit
- SARS-CoV-2
- Acute COVID-19
- Blood sample